-
60 mins
- Women in Advanced Therapies Congress
- Roundtable
Focus: the operational reality of building companies and careers in CGT/biotech -
60 mins
- Women in Advanced Therapies Congress
- Workshop
This highly interactive session connects participants with experienced professionals for focused, small-group discussions. Designed to go beyond informal advice, each interaction is structured around real challenges and actionable guidance.
-
Theatres 1 & 260 mins
- Women in Advanced Therapies Congress
- Workshop
Networking is often cited as critical but rarely taught. This session breaks down how to build and use networks with intention, particularly in an industry where access is uneven. Participants will map their current network, identify gaps, and define targeted actions to build meaningful, opportunity-driven connections.
-
Workshop Room30 mins
- Women in Advanced Therapies Congress
-
Workshop Room30 mins
- Women in Advanced Therapies Congress
Participants bring real challenges, from accessing funding to building teams or navigating leadership barriers, and the panel works through them live. Rather than discussing general trends, this sessi ...
-
Workshop Room20 mins
- Women in Advanced Therapies Congress
The value of WiAT lies in the people in the room, but too often, that potential goes untapped. This speed networking session is designed to actively surface expertise, experience, and opportunities ac ...
-
Workshop Room5 mins
- Women in Advanced Therapies Congress
-
Superlocal, Port Olímpic, Barcelona90 minsJoin our annual kick-off welcome party taking place at sunset along Barcelona beach!Gift of Life Biologics
-
Theatre 1&25 mins
- Plenary
-
Theatre 1&240 mins
- Plenary
From legislation to execution: What ATMP developers must change now in regulatory, CMC and evidence planning to stay aligned with EU reform over the next 12 months. Fixing fragmentation where it hurts ...
-
Theatre 1&235 mins
- Plenary
‘We are still waiting’: What patients and caregivers across Europe experience today - from diagnosis delays to eligibility dead-ends and why ATMP access remains inconsistent despite scientific progres ...
-
Theatre 1&240 mins
- Plenary
Speed breaks first: Why Europe still loses ATMP programmes at the trial-start and scale-up stages and what can be fixed in the next 12 months around approvals, site readiness and cross-border trial ex ...
-
Exhibition Hall45 mins
- Networking Break
-
Theatre 115 mins
- Cell & Gene Therapy Clinical Pathways
-
Theatre 215 mins
- Operational & Commercial Performance
-
Theatre 115 mins
- Cell & Gene Therapy Clinical Pathways
-
Theatre 215 mins
- Operational & Commercial Performance
Biology isn’t the only limiter anymore: As in vivo programmes advance, why delivery consistency, biodistribution insight and execution infrastructure are becoming the real differentiators. Where momen ...
-
Theatre 130 mins
- Cell & Gene Therapy Clinical Pathways
A view on the latest clinical trials, innovations and trends coming out of Europe, US and further afield and what practical coordination would make cross-border trials, faster, simpler and more attrac ... -
Theatre 230 mins
- Operational & Commercial Performance
Session Overview Advanced therapies are stretching not just science and regulation but the very design of capital itself. Across Europe, a growing sentiment has emerged that traditional venture capita ...
-
Theatre 130 mins
- Cell & Gene Therapy Clinical Pathways
Efficacy data as a scaling input, not an endpoint: How Phase I expansion and Phase II data should actively inform tech transfer, manufacturing readiness and comparability so scale-up and fundraising d ...